Voltage-gated sodium channels are inhibited by many local anesthetics, antiarrhythmics, and antiepileptic drugs. The local anesthetic lidocaine appears to be able to access its binding site in the sodium channel only from the membrane phase or from the internal face of the channel. In contrast, the antiepileptic drug carbamazepine was found to inhibit voltage-gated sodium channels only with external but not internal application, implying a major difference. We investigated this point using both wholecell and inside-out patch recordings from human Nav1.7 channels in a stable cell line. In the whole-cell configuration, carbamazepine inhibited sodium current within seconds when applied externally but had very little no effect when applied internally for up to 15 minutes, confirming previous results. However, carbamazepine inhibited sodium channels effectively and rapidly when applied to the internal face of the membrane using inside-out patch recording. We found that lidocaine also has little or no effect when applied intracellularly in whole-cell recording but blocks effectively and rapidly when applied to the internal surface using inside-out patches. In contrast, the cationic lidocaine derivative QX-314 (N-ethyl-lidocaine) blocks effectively when applied internally with whole-cell dialysis as well as when applied to inside-out patches. We conclude that carbamazepine and lidocaine access the sodium channel in similar ways and hypothesize that their lack of effect with internal dialysis in whole-cell recording reflects rapid exit through membrane near the pipette recording site. This effect likely limits the ability of any compound with significant membrane permeability to be applied intracellularly by whole-cell dialysis.
Introduction
Anticonvulsants are used in the treatment of antiepileptic seizures and, in some cases, also for treating neuropathic pain and bipolar affective disorder (reviewed by Rogawski and Loscher, 2004) . Many antiepileptic drugs, including carbamazepine, phenytoin, and lamotrigine, inhibit voltage-dependent sodium channels. At clinical concentrations, inhibition of sodium channels is only partial and the degree of inhibition is modulated by both resting potential ("voltage-dependence") and frequency of action potentials ("usedependence"). Both effects likely reflect stronger binding to inactivated states of the channel compared to the resting state (Willow et al., 1985; Kuo et al., 1997; Ragsdale et al., 1991; Sheets et al., 2008) and, in the case of use-dependence, possibly tight binding to open states as well. Despite considerable structural differences, carbamazepine, phenytoin, and lamotrigine have been shown to share a common binding site (Kuo, 1998; Lipkind and Fozzard, 2010) . In addition, mutagenesis studies suggest that the binding site for anticonvulsants is formed by pore-lining residues and overlaps at least partially with the binding site for local anesthetics and tricyclic antidepressants (Ragsdale et al., 1994; Ragsdale et al., 1996; Yarov-Yaravoy et al., 2001 , 2002 Tsang et al., 2005; Yang et al., 2010) .
Because sodium channel inhibition is only partial and changes with neuronal activity, an important aspect in understanding anticonvulsant drug action is how the kinetics of drug binding and unbinding depend on access of drug molecules to different states of the channel. The voltage-dependence and use-dependence of anticonvulsants is broadly similar to that of lidocaine, for which the hypothesis of tight drug binding to inactivated and open channels was originally introduced (Hille, 1977b) . In the case of lidocaine, it was found that the quaternary cationic derivative QX-314 was unable to block sodium channels when applied externally, while blocking effectively when applied internally (Frazier et al., 1970; Strichartz, 1973) . Similarly, studies examining pH-dependence of action of lidocaine concluded that the protonated (cationic) form of the drug cannot directly access the sodium channel from the outside of the membrane and further concluded that the unprotonated (neutral) form can rapidly permeate through the membrane to quickly provide an equal concentration of intracellular molecules when applied externally (Hille, 1977a; Schwarz et al., 1977) . These studies also raised the This article has not been copyedited and formatted. The final version may differ from this version.
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In the case of carbamazepine, a different picture for channel access was suggested by experiments comparing external and internal application of the drug (Kuo, 1998) .
These experiments found that internal application of carbamazepine (using dialysis in whole-cell recording) had no effect, while external application of the same concentration blocked effectively. Similar results were obtained for phenytoin and lamotrigine (Kuo, 1998) . These experiments suggested that the route of access for binding and unbinding of anticonvulsants may be different than for local anesthetics like lidocaine.
In this study, we examine the inhibition of cloned Nav1.7 channels by carbamazepine applied externally and internally using both whole-cell and inside-out configurations. We find that carbamazepine can access Nav1.7 channels rapidly with internal application in inside-out patches, while having little effect when dialyzed into cells by whole-cell recording. Parallel experiments with lidocaine show an identical difference with internal application in whole-cell versus inside-out patch recordings, suggesting that the pathways for channel access of carbamazepine and lidocaine are similar.
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Materials and Methods
Cell culture HEK293 cells stably expressing human Nav1.7 channel (Liu et al., 2012) were grown in Minimum Essential Medium (ATCC) containing 10% fetal bovine serum (Sigma) and penicillin/streptomycin (Sigma) under 5% CO 2 at 37°C. For electrophysiological recording, cells were grown on coverslips for 12 to 24 h after plating.
Electrophysiology. Whole-cell recordings were obtained using patch pipettes with resistances of 2-3.5 MΩ when filled with the standard internal solution, consisting of 61 mM CsF, 61 mM CsCl, 9 mM NaCl, 1.8 mM MgCl 2 , 9 mM EGTA, 14 mM creatine phosphate (tris salt), 4 mM MgATP, and 0.3 mM GTP (tris salt), 9 mM HEPES, pH adjusted to 7.2 with CsOH. The shank of the electrode was wrapped with Parafilm in order to reduce capacitance and allow optimal series resistance compensation without oscillation. Seals were obtained and the whole-cell configuration established with cells in
Tyrode's solution (155 mM NaCl, 3.5 mM KCl, 1.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, pH adjusted to 7.4 with NaOH) with 10 mM TEACl. To ensure complete dialysis with pipette solution, recordings began after 5 to 10 min after establishment of the whole-cell configuration. Experiments with QX-314 dialysis in whole-cell were originally done as part of a different series and used the same internal solution but a slightly different external solution with reduced chloride: 113 mM Nagluconate, 38 mM NaCl, 2.5 mM KCl, 1 mM CaCl 2 , 10 mM HEPES, 13 mM glucose, pH adjusted to 7.2 with NaOH. The reduced external chloride would be very unlikely to influence the rate of block by internal QX-314.
Inside-out recordings were obtained using patch pipettes with resistances of 1.1-2 MΩ, filled with Tyrode's solution supplemented by 10 mM TEACl. The inside-out configuration was established in a solution consisting of 67.5 mM CsF, 67.5 mM CsCl, 10 mM NaH 2 PO 4 , 10 mM HEPES, 10 mM EGTA, pH adjusted to 7.4 with CsOH.
The amplifier was tuned for partial compensation of series resistance (typically 70-80% of a total series resistance of 4-10 MΩ), and tuning was periodically re-adjusted during the experiment. Currents were recorded at room temperature (21-23°C) with an Axopatch 200 amplifier and filtered at 5 kHz with a low-pass Bessel filter. Currents were digitized using a Digidata 1322A data acquisition interface controlled by pClamp9.2 software This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Carbamazepine inhibits Nav1.7 channels by external but not internal application in whole-cell recording.
We first examined the efficacy of carbamazepine inh ibition of Nav1.7 channels with extracellular application in whole-cell recording.
HEK293 cells expressing Nav1.7 channels were clamped in whole-cell configuration, and sodium current was evoked by depolarizing test pulses to -20 mV. Externally applied carbamazepine immediately reduced sodium current and the effect was completely reversible ( Figure 1A ), as previously described (Willow et al., 1985) . In collected results, 300 μM carbamazepine reduced sodium current by 65 ± 1% (Fig. 1D , n = 4), tested with a protocol using 30-msec test pulses to -20 mV delivered every 3 seconds from a holding potential of -75 mV. As expected, carbamazepine block was strongly use-dependent (Willow et al., 1985; Theile and Cummins, 2011) , with block greatly enhanced by stimulating at 10 Hz rather than 0.33 Hz, and also strongly voltage-dependent (Kuo et al., 1997; Kuo, 1998) , with the steady-state inactivation curve shifted ~ 20 mV in the hyperpolarizing direction by 100 μM carbamazepine (data not shown).
Next, we examined the effect of internal carbamazepine by 300 μM carbamazepine added to the pipette solution in whole-cell recording. With internal 300 μM carbamazepine, the sodium current declined only slightly, falling by 13 ± 4% (n = 5) over 10 min. This result agrees with previous experiments showing little or no effect of internally-applied carbamazepine in whole-cell recordings of sodium current in CA1
neurons (Kuo, 1998) . Figure 1C shows an experiment in which a cell was dialyzed for 10 minutes with internal solution containing 300 μM carbamazepine, which had little effect, and then exposed additionally to externally-applied 300 μM carbamazepine, which produced immediate block to ~30% of control. In collected results, external application of 300 μM carbamazepine to cells already dialyzed for 10 minutes with internal solution containing 300 μM carbamazepine inhibited current by 63 ± 5%, essentially identical (p = 0.7, paired t test) to the inhibition seen with external application to control cells ( 
Carbamazepine inhibits sodium current when applied to the intracellular side in inside-out patch recordings
To test in another way whether carbamazepine applied to the intracellular side of the channels can inhibit sodium currents, we used application to inside-out patches. In initial studies using inside-out patches, we found that there was very little sodium current when steps were given from a holding potential of -75 mV. This turned out to reflect a large shift in the voltage-dependence of inactivation between whole-cell and inside-out patch recordings ( Figure 2 ). In whole-cell recordings, the inactivation curve (tested using 1-second prepulses) could be fit well by a Boltzmann function, with an average midpoint of -70 ± 1 mV and slope factor of 5.7 ± 0.1 (n = 4). In inside-out patches, the mid-point of inactivation shifted in the hyperpolarizing direction by 24 mV (midpoint -94 ± 3 mV; P = <.0001, paired t test), while the slope factor was little different (k = 5.5 ± 0.3; P = 0.3, paired t test) (n = 5). The voltage-dependence of activation may also have been somewhat shifted but we did not investigate this in detail, as a test step to -20 mV worked well in both whole-cell recordings and excised patch recordings. Hyperpolarizing shifts in gating with excised patch recording have been observed previously for native sodium channels in cardiac muscle (Cachelin et al., 1983) , where they were much larger (40-50 mV for both activation and inactivation). Whether the smaller shifts we saw reflect intrinsic differences between Nav1.7 and Nav1.5 channels or differences in recording solutions would require further investigation to determine.
To account for the shift in voltage-dependence of inactivation in inside-out patches, we examined the effects of carbamazepine using a holding potential of -100 mV, at which ~70% of channels were available, similar to the holding potential of -75 mV used in whole-cell recording (Figure 2 ). In striking contrast to the effects of intracellular dialysis in whole-cell recording, application of 300 μM carbamazepine to the intracellular face of inside-out patches produced immediate and dramatic block (Fig. 3A, B) . On average, 300
μM carbamazepine applied to inside-out patches reduced the sodium current by 67 ± 5%.
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The degree of block with application of 300 μM carbamazepine to the intracellular face of inside-out patches was essentially identical to that with extracellular application in whole-cell recording when studied with the same degree of resting inactivation, and in both cases, block occurred within seconds. This suggests that carbamazepine can equilibrate with its binding site from either side of the membrane.
Intracellular lidocaine blocks weakly with whole-cell dialysis but strongly in inside-out patches
We next compared the effects of lidocaine applied to the extracellular or intracellular face of the membrane to the effects of carbamazepine. As expected, lidocaine applied externally inhibited currents effectively and rapidly. At 300 μM, external lidocaine inhibited current by 77 ± 6% (n=5) (Fig. 4A ). The effect of extracellular lidocaine was very rapid, as previously seen for rapid application of lidocaine to frog node of Ranvier (Hille, 1977a) . The effect was complete within one second and reversed within two seconds. However, similar to carbamazepine, intracellular application of the same concentration of lidocaine in whole-cell dialysis had little effect, producing only a small and slow decline in current (Fig. 4B,C) . On average, there was a reduction in current by 21 ± 9% (n=4) over 15 minutes with internally applied 300 μM lidocaine. As with carbamazepine, subsequent additional application of 300 μM lidocaine externally produced rapid block even after a long period of dialysis with the same concentration of intracellular lidocaine (Fig. 4C) . In fact, the block produced by 300 μM external lidocaine applied after 10 minutes of dialysis with 300 μM internal lidocaine was just as effective (block by 83 ± 3%, n=5, relative to the current just before application of external lidocaine) as when 300 μM external lidocaine was applied to cells without intracellular dialysis of lidocaine (block by 77 ± 6%, n=5), as if intracellular lidocaine had little or no effect.
However, when lidocaine was applied to intracellular face of the membrane of insideout patches, it blocked effectively (Fig. 4D,E) . In collected results (Fig. 4F ) application of 300 μM lidocaine at a holding potential of -100 mV produced 57 ± 3% block. As for This article has not been copyedited and formatted. The final version may differ from this version. application of carbamazepine, block by lidocaine applied to inside-out patches was rapid and also quickly reversible.
In contrast with the strikingly different efficacy with which lidocaine acts when applied internally by whole-cell dialysis or by application to inside-out patches, we found that the cationic lidocaine derivative QX-314 was highly effective when applied internally either by whole-cell dialysis (Fig. 4H) or directly to the inside-out surface of inside-out patches (Fig. 4I,J) . At 300 μM, QX-314 produced nearly block (99 ± 0.2%) within 6-7 minutes of whole-cell dialysis (n=5) and block of 78 ± 3% when applied to inside-out patches (n=6) for 1 minute. Block of currents by QX-314 when applied to inside-out patches was faster than with whole-cell dialysis, as expected if dialysis in whole cell recording takes some time to reach completion. Thus, both lidocaine and QX-314 block effectively when applied to the internal surface of inside-out patches while only QX-314 but not lidocaine blocks effectively when applied by whole-cell dialysis. As expected from previous experiments using various types of native neuronal channels (Frazier et al., 1970; Strichartz, 1973) , QX-314 applied extracellularly had little or no effect on Nav1.7 channels (Fig. 4G, n=3 , 1 mM QX-314).
Discussion
We found that carbamazepine rapidly blocks sodium channels when applied to the intracellular face of the membrane using inside-out patches. The block is just as effective and rapid as when carbamazepine is applied to the extracellular face of the membrane in whole-cell recordings. Thus, carbamazepine can reach its binding site on the channel equally effectively when applied from either side of the membrane.
In contrast to application to inside-out patches, application of carbamazepine by intracellular dialysis using whole-cell recording had essentially no blocking effect.
Lidocaine applied by intracellular dialysis in whole-cell recording also had very little effect, but again blocked effectively when applied to the internal surface in inside-out patch recording. The parallel results with carbamazepine and lidocaine suggest that they have similar routes of access to their binding sites in the channel.
The lack of effect of either carbamazepine or lidocaine when applied by intracellular dialysis in whole-cell recording suggests that this mode of application fails to achieve substantial concentrations of drug molecules in the vicinity of most channels in the cell membrane. These results are reminiscent of experiments in which lidocaine and other local anesthetics were applied to nodes of Ranvier either externally, where they blocked rapidly and effectively, or instead applied to the cut ends of the nerve fibers to diffuse intracellularly to the inside surface of the node, in which case they had weak effects. These experiments initially led to the conclusion that local anesthetics could access sodium channels only from the outside of the membrane but not the inside (Khodorov et al., 1976) . However, these experiments were re-interpreted by Hille (1977a), who argued that because the drugs are hydrophobic, they should cross the nerve membrane very rapidly and quickly equilibrate to have equal concentrations inside and outside, regardless of which side they are applied from. He therefore suggested that the weaker potency with application to cut ends of the fiber simply reflected a longer distance to diffuse to the nodal membrane. the extracellular value. These considerations predict that clamping of drug concentrations near both surfaces of the membrane to near the extracellular concentration will also occur in the case that the drug is present only in the pipette, where the extracellular concentration is zero.
The geometry is very different in the case of an inside-out patch. In this case, the internal surface of the membrane is in contact with an effectively infinite reservoir of drug molecules in the bulk solution, so that with rapid movement of drug across the membrane, the drug concentration just inside the pipette (on the extracellular face of the inside-out patch of membrane) will quickly be clamped to the same concentration as in the bulk solution, at the internal face. Drug molecules will diffuse up into the pipette shank and establish a concentration gradient within the pipette, but as long as entry through the membrane is faster than diffusion up the narrow lumen of the pipette near the tip, the drug concentration near the extracellular face of the membrane will be quickly clamped to that in the bulk solution. This picture then predicts that block with drug applied to the internal surface of an inside-out patch should be equally rapid and effective as block produced with extracellular application in whole-cell mode, as we observed.
As pointed out by Hille (1977a), because of the rapid equilibration across the membrane of lipophilic drugs like lidocaine, it is impossible to determine an external versus internal site of action by applying such drugs to one side or another of the membrane. In the case of lidocaine, more information on the accessibility of the binding comes from the cationic derivative QX-314, which does not block from the external side but does block from the internal side of the membrane, suggesting that charged drug molecules can enter the channel only from the inside but not outside of the channel.
Because QX-314 is not membrane-permeant, the experiments are not confounded by the rapid permeation through the membrane expected from lidocaine.
In the absence of charged derivatives of carbamazepine or other anticonvulsant molecules, similar experiments have not been done with these molecules. However, mutagenesis experiments have shown that binding of local anesthetics and carbamazepine are affected in a similar manner by mutating several residues in the domain IV S6 region of the sodium channel protein, suggesting a common binding site (Ragsdale et al., 1996; Tsang et al., 2005; Lipkind and Fozzard 2005) . A shared binding site is also suggested by experiments examining shifts in the voltage-dependence of inactivation produced by combined application of lidocaine and carbamazepine, which suggest mutually exclusive binding to a shared binding site (Yang et al., 2010) . It is then reasonable that the routes of access of the different drug molecules might also be similar.
A primary conclusion from our results is that any compound with substantial membrane permeability cannot effectively be applied by intracellular dialysis in wholecell recordings, as illustrated by the striking contrast in efficacy between application to inside-out patches and application by whole-cell dialysis seen for both carbamazepine and lidocaine. Very likely, the efficacy of dialysis possible with whole-cell recording will depend on the lipophilicity of the compound. Both carbamazepine and lidocaine are highly lipophilic, with a octanol-water partition coefficient of about 200 for carbamazepine and about 43 for lidocaine at pH 7.4 (accounting for the ~75% of lidocaine at pH 7.4 in the protonated form with low lipophilicity) (Sangster, 2013) .
Highly lipophilic compounds like carbamazepine and lidocaine will essentially be soaked up by the cell membrane near the patch pipette as rapidly as they diffuse into the cell through the pipette tip and then be rapidly lost to the extracellular solution. For compounds with less membrane permeability, the intracellular concentration that can be achieved will depend on the balance between the rate of delivery by diffusion through the pipette tip and the rate of loss by permeation through the membrane. For compounds with any significant membrane permeability, however, it can be expected that the concentration achieved inside the cell with whole-cell recording is much less than the pipette concentration -a consideration for any membrane-permeant reagent that might be applied inside the pipette, e.g. for reasons of economy.
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